Eleonora Monteleone Pasquetti
Overview
Explore the profile of Eleonora Monteleone Pasquetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gacci M, Saleh O, Giannessi C, Detti B, Livi L, Monteleone Pasquetti E, et al.
BMC Urol
. 2015 Jul;
15:65.
PMID: 26148853
Background: Radiotherapy is one of the treatment options for prostate cancer (PCa) but up to 25% of men report about severe nocturia (nocturnal voiding). The combination of hyaluronic acid (HA)...
2.
Detti B, Franceschini D, Saieva C, Di Brina L, Baki M, Meattini I, et al.
Cancer Invest
. 2015 Jul;
33(7):329.
PMID: 26135542
No abstract available.
3.
Paiar F, Di Cataldo V, Zei G, Monteleone Pasquetti E, Cecchini S, Meattini I, et al.
Oncol Rev
. 2015 May;
6(1):e1.
PMID: 25992199
Nasopharyngeal carcinoma (NPC) is a unique malignant head and neck cancer with clinical, demographic, and geographic features distinct from other head and neck epithelial malignancies. Non-keratinizing, poorly differentiated, and undifferentiated...
4.
Detti B, Beatrice D, Franceschini D, Davide F, Saieva C, Calogero S, et al.
Cancer Invest
. 2014 Sep;
32(9):445-50.
PMID: 25259606
We present a single-institution experience reporting the efficacy and safety of docetaxel, administered as first-line chemotherapy, in castration-resistant prostate cancer (CRPC), focusing on patients and treatment parameters. From November 2004...
5.
Franceschini D, Paiar F, Meattini I, Agresti B, Monteleone Pasquetti E, Greto D, et al.
Laryngoscope
. 2013 Jun;
123(12):E97-103.
PMID: 23775348
Objectives/hypothesis: To review toxicity and outcomes in patients with head and neck cancer treated with simultaneous integrated boost-intensity-modulated radiotherapy (SIB-IMRT). Study Design: Review of experience with the SIB-IMRT technique. Methods:...